Gemstone Biotherapeutics For Profit
StemBioSys develops proprietary stem cell technologies for the regenerative medicine market.
Estimated Revenue:
$10M to $50M
Industry:
Regenerative medicine
Investors Number:
5
Technology:
Other
Headquarters:
United States
Total Funding:
$69.9M
Last Funding Type:
Post-IPO Equity